Lansen Pharmaceutical Holdings Ltd banner
L

Lansen Pharmaceutical Holdings Ltd
F:1LP

Watchlist Manager
Lansen Pharmaceutical Holdings Ltd
F:1LP
Watchlist
Price: 0.244 EUR 0.83% Market Closed
Market Cap: €100m

Wall St Price Targets

1LP Price Targets Summary
Lansen Pharmaceutical Holdings Ltd

There are no price targets for 1LP.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Lansen Pharmaceutical Holdings Ltd Competitors:
Price Targets
CXT
Crane NXT Co
34% Upside

Revenue
Forecast

2% / Year
Past Growth
0% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
2% / Year
Past Growth
0% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 11 years is 0%.

Gross Profit
Forecast

2% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
2% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Lansen Pharmaceutical Holdings Ltd

Operating Income
Forecast

3% / Year
Past Growth
-2% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
3% / Year
Past Growth
-2% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 11 years is -2%.

Pre-Tax Income
Forecast

1% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
1% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Lansen Pharmaceutical Holdings Ltd

Net Income
Forecast

1% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
1% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Net Income Forecast
is not available for Lansen Pharmaceutical Holdings Ltd
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 1LP's stock price target?
Not Available

1LP does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Lansen Pharmaceutical Holdings Ltd?
Projected CAGR
0%

Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 11 years is 0%.

What is the Operating Income forecast for Lansen Pharmaceutical Holdings Ltd?
Projected CAGR
-2%

Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 11 years is -2%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett